Sciencast Management LP acquired a new stake in Teradyne, Inc. (NASDAQ:TER - Free Report) during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm acquired 34,198 shares of the company's stock, valued at approximately $2,825,000.
Several other hedge funds and other institutional investors also recently made changes to their positions in TER. Berbice Capital Management LLC lifted its position in Teradyne by 200.0% in the 1st quarter. Berbice Capital Management LLC now owns 300 shares of the company's stock valued at $25,000 after acquiring an additional 200 shares in the last quarter. Manchester Capital Management LLC lifted its holdings in shares of Teradyne by 44.7% in the first quarter. Manchester Capital Management LLC now owns 453 shares of the company's stock valued at $37,000 after purchasing an additional 140 shares in the last quarter. Brooklyn Investment Group boosted its position in shares of Teradyne by 189.9% during the first quarter. Brooklyn Investment Group now owns 461 shares of the company's stock valued at $38,000 after buying an additional 302 shares during the last quarter. Sentry Investment Management LLC bought a new stake in Teradyne during the first quarter worth $45,000. Finally, AdvisorNet Financial Inc grew its holdings in Teradyne by 319.0% during the first quarter. AdvisorNet Financial Inc now owns 595 shares of the company's stock worth $49,000 after buying an additional 453 shares in the last quarter. 99.77% of the stock is owned by institutional investors.
Insiders Place Their Bets
In related news, CEO Gregory Stephen Smith sold 554 shares of the business's stock in a transaction dated Tuesday, August 12th. The stock was sold at an average price of $106.00, for a total value of $58,724.00. Following the sale, the chief executive officer directly owned 96,993 shares in the company, valued at approximately $10,281,258. The trade was a 0.57% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Company insiders own 0.16% of the company's stock.
Teradyne Stock Performance
TER traded down $2.26 during midday trading on Thursday, reaching $115.56. The company had a trading volume of 4,023,672 shares, compared to its average volume of 3,504,017. The business has a 50-day moving average price of $105.29 and a two-hundred day moving average price of $91.69. Teradyne, Inc. has a 12-month low of $65.77 and a 12-month high of $144.16. The stock has a market cap of $18.38 billion, a PE ratio of 39.99, a P/E/G ratio of 2.42 and a beta of 1.80.
Teradyne (NASDAQ:TER - Get Free Report) last posted its quarterly earnings results on Tuesday, July 29th. The company reported $0.57 EPS for the quarter, topping analysts' consensus estimates of $0.54 by $0.03. Teradyne had a net margin of 16.59% and a return on equity of 18.16%. The company had revenue of $651.80 million for the quarter, compared to analysts' expectations of $649.02 million. During the same quarter in the previous year, the firm posted $0.86 EPS. Teradyne's revenue was down 10.7% on a year-over-year basis. Teradyne has set its Q3 2025 guidance at 0.690-0.870 EPS. On average, research analysts anticipate that Teradyne, Inc. will post 3.88 earnings per share for the current year.
Teradyne Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Monday, September 29th. Stockholders of record on Friday, September 5th will be paid a dividend of $0.12 per share. The ex-dividend date is Friday, September 5th. This represents a $0.48 annualized dividend and a dividend yield of 0.4%. Teradyne's dividend payout ratio is presently 16.61%.
Wall Street Analyst Weigh In
A number of equities analysts have issued reports on TER shares. Cowen reaffirmed a "buy" rating on shares of Teradyne in a report on Wednesday, July 30th. Cantor Fitzgerald set a $105.00 price target on shares of Teradyne and gave the stock an "overweight" rating in a report on Tuesday, June 24th. JPMorgan Chase & Co. reaffirmed a "neutral" rating and issued a $102.00 price objective (up from $88.00) on shares of Teradyne in a research report on Thursday, July 17th. The Goldman Sachs Group reissued a "sell" rating and set a $85.00 target price on shares of Teradyne in a research report on Wednesday, July 30th. Finally, Morgan Stanley raised Teradyne from an "underweight" rating to an "equal weight" rating and upped their target price for the company from $74.00 to $100.00 in a report on Thursday, July 31st. One investment analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating, five have issued a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $114.44.
Get Our Latest Research Report on Teradyne
Teradyne Profile
(
Free Report)
Teradyne, Inc designs, develops, manufactures, and sells automated test systems and robotics products worldwide. It operates through four segments; Semiconductor Test, System Test, Robotics, and Wireless Test. The Semiconductor Test segment offers products and services for wafer level and device package testing of semiconductor devices in automotive, industrial, communications, consumer, smartphones, cloud, computer and electronic game, and other applications.
Further Reading

Before you consider Teradyne, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teradyne wasn't on the list.
While Teradyne currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.